Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.

@article{Jain2010AzithromycinIA,
  title={Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.},
  author={Raksha Jain and Ramsey R. Hachem and Matthew R Morrell and Elbert P. Trulock and Murali M. Chakinala and Roger D. Yusen and Howard J Huang and Thalachallour Mohanakumar and G. Alexander Patterson and Michael J. Walter},
  journal={The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation},
  year={2010},
  volume={29 5},
  pages={531-7}
}
BACKGROUND Previous studies have suggested that azithromycin improves lung function in lung transplant recipients with bronchiolitis obliterans syndrome (BOS). However, these studies did not include a non-treated BOS control cohort or perform survival analysis. This study was undertaken to estimate the effect of azithromycin treatment on survival in lung transplant recipients with BOS. METHODS We conducted a retrospective cohort study of consecutive lung transplant recipients who developed… CONTINUE READING
39 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 39 extracted citations

Similar Papers

Loading similar papers…